Consider This from NPR Folgen

For the second time this summer the top Republican in the Senate, Minority Leader Mitch McConnell, abruptly went silent at a news conference. He was about to answer a question from a reporter when he suddenly froze up. He seemed unable to speak. An aide then stepped in, trying to keep things moving along.The senator's silences have raised concerns about his mental fitness – and larger questions about an aging Congress.NPR's Mary Louise Kelly speaks with Dr. Ann Murray, the Movement Disorders division chief at the Rockefeller Neurosciences Institute at West Virginia University.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

When people find themselves in the path of a hurricane they are faced with the question: should they evacuate or not? Who makes that call and how? NPR's Mary Louise Kelly speaks with former FEMA administrator Craig Fugate about the decision-making process behind evacuation orders and why people should heed them ahead of hurricanes making landfall.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

On Tuesday, the Biden administration released a list of 10 medications that it's planning to negotiate prices for Medicare in an effort to bring down the costs of some of the most expensive drugs. It's part of a reform included in the Inflation Reduction Act. Many on the list are life-saving drugs that treat diabetes, cancer and other major health problems.|The new prices that the federal government will eventually negotiate for these prescription drugs won't actually go into effect until 2026, and that's only if it doesn't get tied up in court with drugmakers. Six pharmaceutical companies who have filed lawsuits against the administration are calling these provisions unconstitutional. Juana Summers speaks with NPR's pharmaceuticals correspondent Sydney Lupkin and Deepa Shivaram at the White House about the battle lines being drawn between the Biden Administration and pharmaceutical companies.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy